platinum has been researched along with Disease Models, Animal in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.14) | 18.7374 |
1990's | 10 (11.36) | 18.2507 |
2000's | 25 (28.41) | 29.6817 |
2010's | 41 (46.59) | 24.3611 |
2020's | 11 (12.50) | 2.80 |
Authors | Studies |
---|---|
Liu, M; Liu, T; Sun, L; Tan, S; Tang, J; Xiao, W; Zhou, X | 1 |
Fan, J; Li, T; Xiao, L; Yu, L; Zhang, H | 1 |
Albertella, MR; Bani, MR; Decio, A; Dellavedova, G; Formenti, L; Ghilardi, C; Giavazzi, R; Leo, E; Staniszewska, AD; Wilson, J | 1 |
Fan, R; Gong, X; Li, X; Ni, T; Su, L; Yang, F; Zhang, X | 1 |
Hao, Y; Li, R; Min, Y; Pan, W; Tian, S | 1 |
Benfenati, F; Boselli, L; Castagnola, V; Cavalli, A; Colombo, E; Cupini, S; Di Marco, S; Mastronardi, V; Pompa, PP; Tarricone, G | 1 |
Anderson, K; Barrie, AM; Bean, LM; Chen, XL; Connolly, DC; Cordasco, EA; Diaz Osterman, CJ; Fisch, KM; Fu, G; Győrffy, B; Heino, J; Jean, C; Jiang, S; Kleinschmidt, EG; Kolev, VN; Li, J; Mark, AM; McHale, MT; Molinolo, A; Ojalill, M; Ozmadenci, D; Pachter, JA; Rappu, P; Schlaepfer, DD; Stupack, DG; Sulzmaier, FJ; Tancioni, I; Taylor, KN; Uryu, S; Weaver, DT; Xu, G | 1 |
Feng, G; Wu, H; Zeng, M; Zhu, S | 1 |
Argyris, PP; Bazzaro, M; Brown, WL; Erickson, BK; Goergen, KM; Harris, RS; Heinzen, EP; Hou, X; Huang, Y; Jarvis, MC; Kaufmann, SH; Lee, SH; Maurer, MJ; Oberg, AL; Serebrenik, AA; Vogel, RI; Weroha, SJ | 1 |
Jiang, G; Kang, J; Li, W; Liu, L; Owusu, L; Wang, J; Wang, X; Xu, X; Zhang, C; Zhang, L; Zhou, L | 1 |
Luo, Y; Pei, S; Xiao, Y; Xu, J; Zhu, X | 1 |
Abakumov, MA; Abdul Razak, IB; Aisa, HA; Akhmirov, RT; Aladinskaya, AV; Allem, JP; Allu, SR; Ambale-Venkatesh, B; Anasori, B; Arizcorreta, A; Armentrout, PB; Baumann, H; Beloglazkina, EK; Ben-Elyiahu, Y; Ber, AP; Berthon, C; Bettelheim, A; Bluemke, DA; Bonsignore, M; Bordet, A; Borruso, A; Boxer, MB; Bress, AP; Brimacombe, KR; Brown, DE; Brüggemann, M; Cafeo, A; Cao, K; Cao, L; Carnicelli, J; Carr, JC; Cavallo, L; Cazin, CSJ; Cheff, DM; Chen, G; Chen, H; Chen, J; Chen, R; Chen-Sankey, JC; Cheng, C; Cheng, Y; Cheruku, RR; Chida, N; Choi, K; Chu, M; Cipolli, M; Colantonio, LD; Collado, A; Cook, J; Cordes, DB; Covey, J; Cuesta-Sancho, S; Davis, MI; Demireva, M; Derington, CG; Di Rosa, G; Dicanio, D; Dong, G; Dontsova, OA; Dormanesh, A; Dovrat, G; Duan, XM; Duarte, DA; Efthymiou, S; Erofeev, AS; Falivene, L; Fang, Y; Feng, D; Fernandes, VRS; Finko, AV; Freitag, TM; Frye, S; Gachot, C; Gao, S; Garanina, AS; Getya, D; Girón-González, JA; Girón-Ortega, JA; Gitsov, I; Gorelkin, PV; Grützmacher, PG; Guo, PY; Gutiérrez-Saborido, D; Habibi, M; Hall, MD; Hayes-Ryan, D; He, ZZ; Henderson, MJ; Herrick, JS; Herrmann, H; Hoang, Y; Hofmann, W; Hollingshead, M; Houlden, H; Hu, L; Huang, B; Huang, Y; Hussain, M; Huynh, HP; Iansa, P; Ivanenkov, YA; Jadhav, A; Jalaludin, B; Jalava, P; Karavadhi, S; Karpasas, M; Katahara, S; Kawel-Boehm, N; Khazanova, ES; King, JB; Klumpp-Thomas, C; Knibbs, LD; Komiya, Y; Komppula, M; Kranidiotis-Hisatomi, N; Krasnovskaya, OO; Kwiezinski, C; Lee, SW; Lee, TD; Leitner, W; Lerner, A; Leskinen, A; Li, B; Li, J; Li, Y; Li, Z; Liang, D; Liao, HB; Lima, JAC; Lin, L; Lin, W; Lin, Z; Liu, H; Liu, K; Liu, L; Liu, Q; Liu, Y; Lu, K; Luo, M; Ma, B; Machulkin, AE; Maimon, E; Majouga, AG; Márquez-Coello, M; Martinez, NJ; McCarthy, C; McIver, A; Meaney, S; Melotti, P; Menin, L; Mertes, S; Michael, S; Missert, JR; Moisy, P; Monda, KL; Mondello, P; Moore, WJ; Mücklich, F; Mues, KE; Muntner, P; Nahra, F; Navar, AM; Nelson, DJ; Nelson, RE; Ni, S; Nicotera, AG; Nimenko, EA; Nolan, SP; O'Donoghue, K; Oestreich, M; Pandey, RK; Pang, RD; Patnaik, S; Pei, W; Petrov, SA; Pevzner, S; Phillips, KS; Pintani, E; Pironti, E; Pokrovsky, VS; Polshakov, VI; Poudel, B; Pragani, R; Presser, V; Qu, H; Rahsepar, AA; Ramsey, MW; Ravotto, L; Ren, D; Ren, G; Ren, L; Rogach, AL; Rohde, JM; Roponen, M; Rosen, BD; Rosenkranz, A; Rosenson, RS; Salpietro, V; Saltykova, IV; Sato, T; Saveliev, OY; Senger, AR; Shafikov, RR; Shataer, D; Shen, M; Shi, Y; Shu, X; Simeonov, A; Skvortsov, DA; Slawin, AMZ; Smirnova, GB; Song, G; Stevens, VW; Stott, GM; Stratmann, F; Su, BJ; Suarez, S; Sugiyama, Y; Tabaczynski, W; Teo, KL; Tolosa, A; Totorika, A; Tracy, EC; Treggiari, D; Tridello, G; Troxler, T; Urban, DJ; Uspenskaya, AA; Vainer, R; Van Hecke, K; van Pinxteren, D; Vanden Broeck, SMP; Vanneman, ME; Vinogradov, SA; Wang, B; Wang, H; Wang, HS; Wang, L; Wang, R; Wang, X; Wang, YQ; Weller, C; Winkler-Heil, R; Xia, F; Xiao, F; Xin, XL; Xing, H; Xu, J; Xu, SL; Xu, Z; Yamane, M; Yamansarov, EU; Yan, T; Yang, BY; Yang, G; Yang, L; Yang, P; Yang, X; Yao, T; Yasgar, A; Ye, N; Yi, H; Yin, C; Yu, DYW; Yu, HY; Yu, J; Yuan, M; Zagefka, H; Zeng, XW; Zhang, H; Zhang, S; Zhang, W; Zhao, D; Zhao, W; Zhao, X; Zheng, H; Zheng, YK; Zhu, X; Zilbermann, I; Zyk, NU; Zyk, NV | 1 |
Duan, Y; He, P; Huang, F; Li, J; Li, Q; Luo, Z; Saleem, F; Shen, C; Shen, Q; Wang, J; Wang, L; Zhang, Y | 1 |
Cao, L; Duanmu, W; Feng, H; Gao, F; Ge, H; Hu, R; Li, F; Tan, L; Tunan, C; Yin, Y; Yuan, J | 1 |
Broggini, M; Damia, G; Guffanti, F; Ricci, F | 1 |
Fohlen, A; Ghegediban, H; Laurent, A; Namur, J; Pelage, JP; Wassef, M | 1 |
Che, CM; Fung, SK; Lok, CN; Wan, PK; Zhang, ZF; Zou, T | 1 |
Blyth, K; Coffelt, S; Dowson, S; Farquharson, M; Kim, J; Kruspig, B; Mason, S; Matzuk, M; McNeish, IA; Murphy, D; Port, J; Stevenson, D; Walton, JB | 1 |
Ayaz Ahmed, KB; Raman, T; Veerappan, A | 1 |
Anbazhagan, V; Ganapathy, V; Ramani, A; Subramaniyan, SB | 1 |
Hasegawa, T; Hirokawa, N; Okuda, H; Saitoh, M; Sakata, KI; Someya, M; Takakuwa, Y; Usami, Y | 1 |
Bielenberg, DR; Chang, J; Fernandes, D; Gartung, A; Hammock, BD; Huang, S; Hwang, SH; Kieran, MW; Panigrahy, D; Schmidt, BA; Sukhatme, VP; Yang, J; Zurakowski, D | 1 |
ArunKumar, G; Bharathan, S; Chandrasekaran, H; Nagarajan, S; Rangappa, G; Subramaniyan, SB; Sundaramoorthy, NS; Veerappan, A | 1 |
Charoonrut, P; Lertsapcharoen, P; Srimahachota, S | 1 |
Ashihara, K; Fujiwara, S; Kanemura, M; Kawaguchi, H; Ohmichi, M; Sasaki, H; Takai, M; Tanabe, A; Tanaka, T; Tanaka, Y; Terai, Y; Tsunetoh, S | 1 |
Hamada, K; Imanaka-Yoshida, K; Matsushima, S; Miura, Y; Miyamoto, K; Suzuki, H; Taki, W; Toma, N; Yoshida, T | 1 |
Beumer, JH; Dienel, S; Eiseman, JL; Horn, CC; Meyers, K; Rigatti, LH; Strychor, S | 1 |
Brockmann, MA; Nikoubashman, O; Pjontek, R; Tolba, R; Wiesmann, M | 1 |
Fortin, D; Paquette, B; Sanche, L; Shi, M | 1 |
Hamasaki, T; Hashimoto, K; Isobe, A; Kawano, M; Kimura, T; Kozasa, K; Kuroda, H; Mabuchi, S; Matsumoto, Y; Morii, E; Sasano, T; Sawada, K; Takahashi, R | 1 |
An, R; Matei, D; Merrill, D; Nolte, D; Sun, H; Turek, J; Yakubov, B | 1 |
Alkema, NG; de Jong, S; van der Zee, AG; van Vugt, MA; Wisman, GB | 1 |
Fujimoto, M; Hamada, K; Imanaka-Yoshida, K; Matsushima, S; Miura, Y; Miyamoto, K; Suzuki, H; Taki, W; Tanemura, H; Toma, N; Yoshida, T | 1 |
Mohana Roopan, S; Samuel, EJ; Titus, D | 1 |
Alard, A; Blank, SV; Curtin, JP; David-West, G; Musa, F; Schneider, RJ | 1 |
Bloomfield, A; Cristescu, R; Dorton, R; Dussault, I; Guertin, AD; Haines, BB; Hinton, MC; Leamon, CP; Lejnine, S; Loboda, A; Nebozhyn, M; Nelson, M; O'Neil, J; Picard, KL; Reddy, JA; Schmidt, EV; Stoeck, A; Vetzel, M; Zhang, T | 1 |
Gu, Z; He, Y; Hu, C; Li, Y; Xu, X; Zhang, X; Zhang, Z | 1 |
Chaudhary, N; Gemmete, JJ; Li, P; Pandey, AS; Thompson, BG; Xi, G; Zhang, C | 1 |
Bian, ZX; Cheng, GY; Chui, CH; Feng, YH; Gambari, R; Ho, CL; Lam, KH; Lam, PL; Lo, YH; Wang, QW; Wong, RS; Wong, WY | 1 |
Carlier, C; Ceelen, W; De Wever, O; Gremonprez, F; Laforce, B; Tucoulou, R; Van Malderen, SJM; Vanhaecke, F; Villanova, J; Vincze, L | 1 |
Ab, O; Bartle, LM; Coccia, J; Lanieri, L; Lee, J; Pinkas, J; Ponte, JF; Ruiz-Soto, R; Themeles, M; Zhou, Y | 1 |
Airhart, S; Chamie, K; Cimino, GD; de Vere White, R; Drakaki, A; Haack, K; Henderson, PT; Lin, TY; Malfatti, M; Ognibene, T; Pan, CX; Tepper, CG; Turteltaub, KW; Wang, SS; Yang, H; Zhang, H; Zimmermann, M | 1 |
Ang, WH; Chin, CF; Ho, HK; Hong Thng, AH; Pang, YY; Yap, SQ | 1 |
Abo-Ramadan, U; Frösen, J; Hernesniemi, JA; Kangasniemi, M; Marjamaa, J; Niemelä, MR; Tulamo, R | 1 |
Berry, JL; Challa, VR; Claus, RO; Geer, CP; Lalli, JH; Mattern, CW; Morris, PP; Mussat-Whitlow, BJ; Whitlow, CT; Yazdani, SK | 1 |
Daneriallis, GM; Egorin, MJ; Goldman, S; Kondo, A; Mania-Farnell, B; Nakazaki, H; Rajaram, V; Soares, MB; Sredni, ST; Tange, Y; Tomita, T | 1 |
Berenstein, A; Niimi, Y; Tsumoto, T | 1 |
Al-Schameri, R; Killer, M; Lametschwantner, A; Minnich, B; Plenk, H; Richling, B | 1 |
Abe, T; Ebara, M; Murayama, Y; Nien, YL; Saguchi, T; Vinters, HV; Vinuela, F; Yuki, I | 1 |
Alvarez, M; Bustos, J; Figueras, F; López, T; Manjarrez, J; Martínez, E; Martínez-Ferre, A; Rodríguez-Reinoso, F; Silvestre-Albero, J | 1 |
Agid, R; Bovi, M; Drexler, AY; Geibprasert, S; Hans, FJ; Krings, T; Ludolph, A; Reinges, MH; Scherer, K; Sellhaus, B | 1 |
Bull, JM; Chan, D; Deng, W; He, G; Proett, JM; Rowe, RW; Siddik, Z; Strebel, FR | 1 |
Ban, M; Goutet, M; Huguet, N; Langonné, I; Pépin, E | 1 |
Abo-Ramadan, U; Antell, H; Hernesniemi, JA; Kangasniemi, M; Marjamaa, J; Niemelä, MR | 1 |
Abe, K; Deguchi, K; Miyamoto, Y; Ohta, Y; Takamiya, M; Yamashita, T | 1 |
Conner, M; Dobbin, ZC; Han, HD; Katre, AA; Landen, CN; Lopez-Berestein, G; Nowsheen, S; Shah, MM; Sood, AK; Steg, AD; Yang, ES; Ziebarth, AJ | 1 |
Ahn, SE; Bazer, FW; Chung, HH; Han, JY; Jeong, W; Kim, HS; Kim, J; Kim, MA; Kim, MK; Kim, YB; Lim, W; Song, G; Song, YS | 1 |
Adlard, PA; Barnham, KJ; Cappai, R; Ciccotosto, G; Cortes, M; Critch, N; Hung, LW; Kenche, VB; Kwok, J; Lal, V; Masters, CL; Murakami, K; Perez, K; Sherratt, N; Volitakes, I | 1 |
Fujiwara, NH; Kallmes, DF | 1 |
Alonso, C; Boxall, FE; Fuertes, MA; Kelland, LR; Montero, EI; Navarro-Ranninger, C; Pérez, JM | 1 |
Itakura, T; Matsumoto, H; Ogawa, A; Terada, T; Tsuura, M | 1 |
Barrocas, AM; Cross, DT; Dacey, RG; Derdeyn, CP; Moran, CJ | 1 |
Albert, M; Becker, V; Franke, UF; Kaluza, M; Lessel, M; Roskos, M; Wahlers, T; Wittwer, T | 1 |
Berenstein, A; Niimi, Y; Silane, M; Song, JK; Yoshino, Y | 1 |
Jupp, B; O'Brien, TJ; Tesiram, YA; Vosmansky, M; Williams, JP | 1 |
Gevry, G; Guilbert, F; Metcalfe, A; Raymond, J; Salazkin, I | 1 |
Cloft, HJ; Dai, D; Danielson, MA; Ding, YH; Helm, GA; Hunter, LW; Kadirvel, R; Kallmes, DF; Lewis, DA; Sieck, GC; Zhan, WZ | 1 |
Consigny, D; Grinde, J; Grum, K; Luty, CM; Pulfer, K; Rappe, A; Strother, CM; Turk, AS | 1 |
Cloft, HJ; Dai, D; Ding, YH; Kadirvel, R; Kallmes, DF; Lewis, DA | 1 |
Dzagnidze, A; Katsarava, Z; Kaube, H; Liedert, B; Limmroth, V; Makhalova, J; Thomale, J; Yoon, MS | 1 |
Burgess, JD; Fang, D; Jiang, D; Kelley, TJ | 1 |
Lamoreux, ML; Orlow, SJ; Pifko-Hirst, S; Zhou, BK | 1 |
Cavaletti, G; Minoia, C; Schieppati, M; Tredici, G | 1 |
Guterman, LR; Hopkins, LN | 1 |
Craciunescu, D; Dreyfuss, G; Loiseau, P; Nicolas, JA; Pénicaut, B | 1 |
Akamo, Y; Manabe, T; Mizuno, I; Mohri, N; Shibata, T; Takeyama, H; Terada, J; Ueda, T; Yamamoto, T; Yotsuyanagi, T | 1 |
Guglielmi, G; Ji, C; Massoud, TF; Viñuela, F | 1 |
Epley, KD; Herling, I; Katz, HR; Lasky, JB | 1 |
Cloft, HJ; Hankins, GR; Helm, GA; Kallmes, DF; Lopes, MB; Williams, AD | 1 |
Cacini, W; Di Iulio, D; Kishore, BK; Krane, CM; Menon, AG | 1 |
Gonzalez, NR; Murayama, Y; Song, JK; Tateshima, S; Viñuela, F; Wallace, MP | 1 |
Criado, JM; de La Fuente, A; Dominguez, MF; Izco-Basurko, I; Macias, RI; Marin, JJ; Monte, MJ; Pascual, MJ; Yajeya, J | 1 |
Altes, TA; de Gast, AN; Do, HM; Helm, GA; Kallmes, DF; Marx, WF | 1 |
Fischer, SJ; Gross, L; McDonald, ES; Windebank, AJ | 1 |
Desfaits, AC; Janicki, C; Leblanc, P; Morel, F; Raymond, J; Roorda, S; Salazkin, I | 1 |
Certad-Fombona, G; Craciunescu, DG; Doadrio-Villarejo, JC; Gayral, P; Loiseau, PM | 1 |
Bömer, U; Gleichmann, E; Haas-Raida, D; Kind, P; Kulig, J; Schuppe, HC | 1 |
deKernion, JB; Persky, L; Rose, D; Soloway, MS | 1 |
5 review(s) available for platinum and Disease Models, Animal
Article | Year |
---|---|
Anticancer metal-N-heterocyclic carbene complexes of gold, platinum and palladium.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Gold; Heterocyclic Compounds; Humans; Ligands; Methane; Molecular Probes; Palladium; Platinum; Sulfhydryl Compounds; Theranostic Nanomedicine | 2018 |
Studying platinum sensitivity and resistance in high-grade serous ovarian cancer: Different models for different questions.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Humans; Mice; Models, Theoretical; Neoplasm Grading; Ovarian Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors | 2016 |
Current scenario of biomedical aspect of metal-based nanoparticles on gel dosimetry.
Topics: Animals; Bismuth; Cell Line, Tumor; Disease Models, Animal; Gadolinium; Gels; Gold; Hafnium; Humans; Iodine; Iron; Metal Nanoparticles; Nanotechnology; Neoplasms; Oxides; Platinum; Radiometry; Radiotherapy Dosage; Silver | 2016 |
Histologic and hemodynamic effects of endosaccular platinum coils for intracranial aneurysms.
Topics: Aneurysm, Ruptured; Animals; Balloon Occlusion; Blood Vessel Prosthesis; Disease Models, Animal; Dogs; Embolization, Therapeutic; Equipment Safety; Female; Hemodynamics; Humans; Intracranial Aneurysm; Magnetic Resonance Angiography; Male; Platinum; Prognosis; Prosthesis Design; Rabbits; Radiography; Risk Assessment; Severity of Illness Index; Sheep; Survival Analysis; Swine; Treatment Outcome | 2004 |
Endovascular treatment of cerebral aneurysms. Diagnosis and treatment.
Topics: Adult; Aged; Animals; Catheterization; Critical Care; Disease Models, Animal; Dogs; Embolization, Therapeutic; Heparin; Humans; Intracranial Aneurysm; Middle Aged; Platinum; Protamines; Rabbits; Stents; Subarachnoid Hemorrhage; Swine | 1993 |
83 other study(ies) available for platinum and Disease Models, Animal
Article | Year |
---|---|
Chronic stress induces platinum and Niraparib resistance in mouse models of ovarian cancer.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Indazoles; Mice, Inbred BALB C; Mice, Inbred C57BL; Middle Aged; Models, Biological; Ovarian Neoplasms; Piperidines; Platinum; Stress, Psychological | 2022 |
A Bio-Inorganic Hybrid Hemostatic Gauze for Effective Control of Fatal Emergency Hemorrhage in "Platinum Ten Minutes".
Topics: Animals; Bandages; Disease Models, Animal; Hemorrhage; Hemostatics; Platinum; Swine; Zeolites | 2022 |
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin.
Topics: Adenocarcinoma; Animals; BRCA2 Protein; Carboplatin; Carcinoma, Ovarian Epithelial; Disease Models, Animal; Female; Heterografts; Humans; Mice; Ovarian Neoplasms; Platinum; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors | 2023 |
Mechanism of action of platinum nanoparticles implying from antioxidant to metabolic programming in light-induced retinal degeneration model.
Topics: Animals; Antioxidants; Disease Models, Animal; Hydrogen Peroxide; Metal Nanoparticles; Mice; Oxidative Stress; Platinum; Retinal Degeneration | 2023 |
Platinum Twin and Triplet Drugs Improve Chemoimmunotherapy.
Topics: Animals; Colorectal Neoplasms; Disease Models, Animal; Immunomodulation; Immunotherapy; Mice; Platinum; Tumor Microenvironment | 2023 |
Platinum Nanozymes Counteract Photoreceptor Degeneration and Retina Inflammation in a Light-Damage Model of Age-Related Macular Degeneration.
Topics: Aged; Animals; Antioxidants; Disease Models, Animal; Humans; Inflammation; Light; Macular Degeneration; Metal Nanoparticles; Platinum; Rats; Rats, Sprague-Dawley; Retina; Retinal Degeneration | 2023 |
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapy.
Topics: Animals; Antineoplastic Agents; Cisplatin; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Focal Adhesion Kinase 1; Humans; Mice; Ovarian Neoplasms; Platinum; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins p21(ras); Signal Transduction; Stem Cells | 2019 |
Platinum Nanoparticles As A Therapeutic Agent Against Dextran Sodium Sulfate-Induced Colitis In Mice.
Topics: Acute Disease; Administration, Oral; Animals; Anti-Inflammatory Agents; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Gastrointestinal Microbiome; Inflammation; Lipopolysaccharides; Male; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Platinum; RAW 264.7 Cells; Signal Transduction | 2019 |
The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Cytidine Deaminase; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gene Expression; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Mice; Minor Histocompatibility Antigens; Ovarian Neoplasms; Platinum; Prognosis; Synthetic Lethal Mutations; Xenograft Model Antitumor Assays | 2020 |
Dihydrotanshinone I inhibits ovarian cancer cell proliferation and migration by transcriptional repression of PIK3CA gene.
Topics: Animals; Carcinoma, Ovarian Epithelial; Cell Death; Cell Line, Tumor; Cell Movement; Cell Proliferation; Class I Phosphatidylinositol 3-Kinases; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Furans; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Ovarian Neoplasms; Phenanthrenes; Phosphatidylinositol 3-Kinases; Platinum; Proto-Oncogene Proteins c-akt; Quinones; Signal Transduction; Transcription, Genetic; Zebrafish | 2020 |
Combined chemotherapy of platinum and fluorouracil promotes T cell-mediated antitumor immunity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Disease Models, Animal; Drug Therapy, Combination; Fluorouracil; Humans; Melanoma; Mice, Inbred C57BL; Neoplasms; NF-kappa B p50 Subunit; Oxaliplatin; Platinum; Stomach Neoplasms; T-Lymphocyte Subsets; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Helper-Inducer | 2021 |
Topics: Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antigens, Surface; Antineoplastic Agents; Antioxidants; Antiviral Agents; Aporphines; Atherosclerosis; Benzoyl Peroxide; beta Catenin; Biofilms; Biomarkers; Brain; Cannabis; Carcinoma, Squamous Cell; Case-Control Studies; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Child; China; Chlorides; Chlorophyll; Cholesterol, LDL; Coinfection; Corylus; Cross-Sectional Studies; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Developmental Disabilities; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Electroencephalography; Environmental Exposure; Enzyme Inhibitors; Epilepsy, Generalized; Ethnicity; Female; Fertilization in Vitro; Fluorescent Dyes; Follow-Up Studies; Forecasting; Glutamate Carboxypeptidase II; Glycine; Half-Life; Head and Neck Neoplasms; Health Communication; Heart Ventricles; Hepacivirus; Hepatitis C; Heterosexuality; HIV Infections; Humans; Hypercholesterolemia; Immunoassay; Inhalation Exposure; Isocitrate Dehydrogenase; Laryngeal Neoplasms; Ligands; Light; Lipopolysaccharide Receptors; Liver Cirrhosis; Lung; Lung Neoplasms; Magnetic Resonance Imaging, Cine; Male; Maternal Age; Mechanical Phenomena; Mice; Mice, Nude; Mice, SCID; Microglia; MicroRNAs; Microscopy, Fluorescence; Microsomes, Liver; Middle Aged; Minority Groups; Mitochondrial Membrane Transport Proteins; Models, Biological; Molecular Structure; Molecular Weight; Monte Carlo Method; Muscle Hypotonia; Mutagenesis, Site-Directed; Mutation, Missense; Natriuretic Peptide, Brain; Neoplasms; Nickel; Nitric Oxide; Optical Imaging; Oxides; Particle Size; Particulate Matter; PCSK9 Inhibitors; Peptide Fragments; Phenotype; Photochemotherapy; Photosensitizing Agents; Phytochemicals; Piper; Placenta Growth Factor; Plant Extracts; Plant Leaves; Plant Stems; Platinum; Point-of-Care Testing; Population Surveillance; Postpartum Period; Pregnancy; Pregnancy, Twin; Prevalence; Prospective Studies; Prostatic Neoplasms; Pseudomonas aeruginosa; Pyridines; Pyridones; Racial Groups; Rats; Respiratory Physiological Phenomena; Retrospective Studies; Risk Factors; RNA, Long Noncoding; Semiconductors; Sexual and Gender Minorities; Sexual Behavior; Social Media; Sodium; Solubility; Stereoisomerism; Stochastic Processes; Structure-Activity Relationship; Substance-Related Disorders; Sustained Virologic Response; Sweat; Temperature; Time Factors; Tissue Distribution; Titanium; Transplantation, Heterologous; Tumor Cells, Cultured; Tungsten; Tyramine; United States; Up-Regulation; Ventricular Dysfunction, Left; Ventricular Function, Left; Veterans; Xenograft Model Antitumor Assays; Young Adult | 2021 |
Ultrathin Two-Dimensional Plasmonic PtAg Nanosheets for Broadband Phototheranostics in Both NIR-I and NIR-II Biowindows.
Topics: Animals; Biosensing Techniques; Cell Line, Tumor; Disease Models, Animal; Infrared Rays; Mice; Nanoparticles; Neoplasms; Photoacoustic Techniques; Photothermal Therapy; Platinum; Silver; Theranostic Nanomedicine | 2021 |
L-Borneol induces transient opening of the blood-brain barrier and enhances the therapeutic effect of cisplatin.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain Neoplasms; Camphanes; Capillary Permeability; Cisplatin; Claudin-5; Contrast Media; Disease Models, Animal; Dose-Response Relationship, Drug; Glioma; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Nervous System Diseases; Occludin; Platinum | 2017 |
Combination of paclitaxel, bevacizumab and MEK162 in second line treatment in platinum-relapsing patient derived ovarian cancer xenografts.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Bevacizumab; Biomarkers; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Humans; Mice; Mutation; Ovarian Neoplasms; Paclitaxel; Platinum; Recurrence; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2017 |
Peripheral Embolization Using Hydrogel-Coated Coils Versus Fibered Coils: Short-Term Results in an Animal Model.
Topics: Animals; Disease Models, Animal; Embolization, Therapeutic; Hydrogel, Polyethylene Glycol Dimethacrylate; Iliac Artery; Platinum; Renal Artery; Sheep; Thrombosis; Treatment Outcome | 2018 |
CRISPR/Cas9-derived models of ovarian high grade serous carcinoma targeting Brca1, Pten and Nf1, and correlation with platinum sensitivity.
Topics: Animals; BRCA1 Protein; BRCA2 Protein; Cell Line, Tumor; Cell Survival; CRISPR-Cas Systems; Cystadenocarcinoma, Serous; Disease Models, Animal; Female; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Grading; Neurofibromin 1; Ovarian Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; PTEN Phosphohydrolase; Survival Rate; Tumor Suppressor Protein p53; Tumor Suppressor Proteins | 2017 |
Jacalin capped platinum nanoparticles confer persistent immunity against multiple Aeromonas infection in zebrafish.
Topics: Adaptive Immunity; Adjuvants, Immunologic; Aeromonas hydrophila; Animals; Disease Models, Animal; Gram-Negative Bacterial Infections; Nanoparticles; Plant Lectins; Platinum; Survival Analysis; Zebrafish | 2018 |
Preparation of self-assembled platinum nanoclusters to combat Salmonella typhi infection and inhibit biofilm formation.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Disease Models, Animal; Metal Nanoparticles; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Microscopy, Fluorescence; Particle Size; Platinum; Salmonella typhi; Surface Properties; Typhoid Fever; Zebrafish | 2018 |
Histopathological differences of experimental aneurysms treated with bare platinum, fibered, and bioactive coils.
Topics: Animals; Disease Models, Animal; Embolization, Therapeutic; Intracranial Aneurysm; Platinum; Swine; Thrombosis; Treatment Outcome | 2019 |
Suppression of chemotherapy-induced cytokine/lipid mediator surge and ovarian cancer by a dual COX-2/sEH inhibitor.
Topics: Animals; Antineoplastic Agents; Bridged-Ring Compounds; Carcinoma, Ovarian Epithelial; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Disease Models, Animal; Disease Progression; Epoxide Hydrolases; Female; Inflammation; Lipids; Macrophages; Mice; Mice, Inbred C57BL; Mice, SCID; Ovarian Neoplasms; Platinum; Signal Transduction; Taxoids | 2019 |
Sub lethal levels of platinum nanoparticle cures plasmid and in combination with carbapenem, curtails carbapenem resistant Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Ceftriaxone; Cell Membrane; Disease Models, Animal; DNA Cleavage; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Gene Transfer, Horizontal; Humans; Meropenem; Metal Nanoparticles; Microbial Sensitivity Tests; Plasmids; Platinum; Zebrafish | 2019 |
Transcatheter ventricular septal defect closure with a new nanoplatinum-coated nitinol device in a Swine model.
Topics: Alloys; Animals; Cardiac Catheterization; Coated Materials, Biocompatible; Disease Models, Animal; Echocardiography; Heart Septal Defects, Ventricular; Nanostructures; Platinum; Prostheses and Implants; Prosthesis Design; Septal Occluder Device; Swine; Treatment Outcome | 2013 |
Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cisplatin; Deoxycytidine; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Mice; Neoplasm Metastasis; Neovascularization, Pathologic; Ovarian Neoplasms; Platinum; Proto-Oncogene Proteins c-akt; Signal Transduction; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2014 |
Gellan sulfate core platinum coil with tenascin-C promotes intra-aneurysmal organization in rats.
Topics: Animals; Disease Models, Animal; Embolization, Therapeutic; Intracranial Aneurysm; Male; Platinum; Polysaccharides; Rats; Rats, Sprague-Dawley; Sulfuric Acid Esters; Tenascin | 2014 |
Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain; Chemical and Drug Induced Liver Injury; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Emetics; Female; Half-Life; Injections, Intraperitoneal; Kidney; Lung; Nausea; Neurons; Platinum; Shrews; Spinal Cord; Substance P; Tissue Distribution | 2015 |
Retrieval of migrated coils with stent retrievers: an animal study.
Topics: Angiography; Animals; Disease Models, Animal; Embolization, Therapeutic; Endovascular Procedures; Equipment Design; Female; Fluoroscopy; Foreign-Body Migration; Intracranial Aneurysm; Platinum; Stents; Subclavian Artery; Swine | 2015 |
Convection-enhancement delivery of platinum-based drugs and Lipoplatin(TM) to optimize the concomitant effect with radiotherapy in F98 glioma rat model.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; Combined Modality Therapy; Convection; Disease Models, Animal; Drug Delivery Systems; Glioma; Maximum Tolerated Dose; Platinum; Rats, Inbred F344; Reproducibility of Results; Survival Analysis; Toxicity Tests, Acute | 2015 |
The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Granulocyte Colony-Stimulating Factor; Mice; Myeloid Cells; Platinum; Prognosis; Uterine Cervical Neoplasms | 2015 |
Intracellular Doppler Signatures of Platinum Sensitivity Captured by Biodynamic Profiling in Ovarian Xenografts.
Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Heterografts; Humans; Mice; Molecular Imaging; Ovarian Neoplasms; Platinum; Tumor Cells, Cultured; Ultrasonography, Doppler | 2016 |
Aneurysm Organization Effects of Gellan Sulfate Core Platinum Coil with Tenascin-C in a Simulated Clinical Setting and the Possible Mechanism.
Topics: Angiography; Animals; Cell Line, Tumor; Disease Models, Animal; Embolization, Therapeutic; Female; Glioma; Intracranial Aneurysm; Male; Matrix Metalloproteinase 9; Platinum; Polysaccharides; Rabbits; Rats; Rats, Sprague-Dawley; Sulfuric Acid Esters; Tenascin; Transforming Growth Factor beta | 2016 |
Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer.
Topics: Allosteric Regulation; Animals; Antineoplastic Agents; Carboplatin; Catalytic Domain; Cell Line, Tumor; Cell Proliferation; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Everolimus; Female; Humans; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Multiprotein Complexes; Ovarian Neoplasms; Platinum; Protein Kinase Inhibitors; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays | 2016 |
High Levels of Expression of P-glycoprotein/Multidrug Resistance Protein Result in Resistance to Vintafolide.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Proliferation; Cluster Analysis; Computational Biology; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Folate Receptors, GPI-Anchored; Folic Acid; Gene Expression; Gene Expression Profiling; Humans; Mice; Platinum; RNA, Messenger; Vinca Alkaloids; Xenograft Model Antitumor Assays | 2016 |
Supramolecular PEGylated Dendritic Systems as pH/Redox Dual-Responsive Theranostic Nanoplatforms for Platinum Drug Delivery and NIR Imaging.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Drug Carriers; Fluorescent Dyes; Heterografts; Humans; Hydrogen-Ion Concentration; Infrared Rays; Mice; Nanoparticles; Oxidation-Reduction; Platinum; Theranostic Nanomedicine; Treatment Outcome | 2016 |
Aspirin and Clopidogrel Inhibit Aneurysm Healing after HydroCoil Implantation in External Carotid Artery Aneurysm Model.
Topics: Aneurysm; Animals; Aspirin; Carotid Artery Diseases; Carotid Artery, External; Cell Movement; Clopidogrel; Disease Models, Animal; Drug Therapy, Combination; Embolization, Therapeutic; Equipment Design; Macrophages; Male; Platelet Aggregation Inhibitors; Platinum; Rats, Sprague-Dawley; Ticlopidine; Time Factors; Wound Healing | 2016 |
Synthesis of platinum(II) and palladium(II) complexes with 9,9-dihexyl-4,5-diazafluorene and their in vivo antitumour activity against Hep3B xenografted mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Disease Models, Animal; Enzyme Activation; Heterografts; Humans; Liver; Liver Neoplasms; Mice; Organoplatinum Compounds; Palladium; Platinum | 2016 |
Nanoscopic tumor tissue distribution of platinum after intraperitoneal administration in a xenograft model of ovarian cancer.
Topics: Animals; Calcium; Cisplatin; Copper; Disease Models, Animal; Female; Fever; Heterografts; Injections, Intraperitoneal; Mass Spectrometry; Mice; Ovarian Neoplasms; Phosphorus; Platinum; Spectrometry, X-Ray Emission; Sulfur; Tissue Distribution; Zinc | 2016 |
Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carboplatin; Cell Cycle; Cell Line, Tumor; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Female; Folate Receptor 1; Humans; Immunoconjugates; Maytansine; Mice; Neovascularization, Pathologic; Ovarian Neoplasms; Platinum; Xenograft Model Antitumor Assays | 2016 |
Microdose-Induced Drug-DNA Adducts as Biomarkers of Chemotherapy Resistance in Humans and Mice.
Topics: Animals; Antineoplastic Agents; Biomarkers; Carboplatin; Cell Line, Tumor; Deoxycytidine; Disease Models, Animal; DNA Adducts; DNA Repair; Drug Resistance, Neoplasm; Drug Synergism; Female; Gemcitabine; Humans; Mass Spectrometry; Mice; Mutation; Neoplasms; Platinum; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2017 |
Finely Tuned Asymmetric Platinum(IV) Anticancer Complexes: Structure-Activity Relationship and Application as Orally Available Prodrugs.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Coordination Complexes; Disease Models, Animal; Drug Stability; Humans; Mice; Molecular Conformation; Oxidation-Reduction; Platinum; Prodrugs; Solubility; Structure-Activity Relationship; Tissue Distribution; X-Ray Diffraction | 2017 |
Occlusion of neck remnant in experimental rat aneurysms after treatment with platinum- or polyglycolic-polylactic acid-coated coils.
Topics: Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Disease Models, Animal; Embolization, Therapeutic; Intracranial Aneurysm; Magnetic Resonance Imaging; Male; Platinum; Polyesters; Postoperative Care; Postoperative Complications; Prostheses and Implants; Radiography; Rats; Rats, Wistar; Thrombosis; Treatment Outcome; Tunica Intima | 2009 |
Endovascular histologic effects of ultrathin gold- or vitronectin-coated platinum aneurysm coils in a rodent arterial occlusion model: a preliminary investigation.
Topics: Animals; Carotid Artery Diseases; Cerebrovascular Disorders; Coated Materials, Biocompatible; Combined Modality Therapy; Disease Models, Animal; Drug Implants; Embolization, Therapeutic; Equipment Design; Equipment Failure Analysis; Fibrinolytic Agents; Male; Materials Testing; Pilot Projects; Platinum; Prosthesis Design; Rats; Rats, Sprague-Dawley; Treatment Outcome; Vitronectin | 2009 |
Interstitial continuous infusion therapy in a malignant glioma model in rats.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Brain; Brain Neoplasms; Carboplatin; Catheterization; Cell Line, Tumor; Corpus Striatum; Disease Models, Animal; Glioma; Kaplan-Meier Estimate; Male; Neoplasm Transplantation; Organoplatinum Compounds; Oxaliplatin; Platinum; Rats; Rats, Inbred F344; Treatment Outcome | 2009 |
Evaluation of the new HydroSoft coil in a canine model of bifurcation aneurysm. Laboratory investigation.
Topics: Angiography, Digital Subtraction; Animals; Cerebral Angiography; Cerebral Arteries; Disease Models, Animal; Dogs; Embolization, Therapeutic; Intracranial Aneurysm; Male; Platinum; Tunica Intima; Vasculitis | 2009 |
Histological demonstration of healing in experimental aneurysms.
Topics: Animals; Disease Models, Animal; Embolization, Therapeutic; Female; Fibrosis; Granulation Tissue; Hydrogel, Polyethylene Glycol Dimethacrylate; Intracranial Aneurysm; Male; Platinum; Postoperative Complications; Prostheses and Implants; Rabbits; Secondary Prevention; Tunica Intima; Wound Healing | 2009 |
A rabbit model for efficacy evaluation of endovascular coil materials.
Topics: Angiography, Digital Subtraction; Animals; Carotid Artery Diseases; Carotid Artery, Common; Cerebral Angiography; Coated Materials, Biocompatible; Disease Models, Animal; Embolization, Therapeutic; Intracranial Aneurysm; Lactic Acid; Materials Testing; Platinum; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Treatment Outcome; Vascular Patency | 2009 |
Catalytic nanomedicine: a new field in antitumor treatment using supported platinum nanoparticles. In vitro DNA degradation and in vivo tests with C6 animal model on Wistar rats.
Topics: Animals; Apoptosis; Biocatalysis; Brain Neoplasms; Cell Proliferation; Disease Models, Animal; DNA; Drug Screening Assays, Antitumor; Male; Metal Nanoparticles; Nanomedicine; Neoplasms, Experimental; Particle Size; Platinum; Rats; Rats, Wistar; Surface Properties | 2010 |
Bare, bio-active and hydrogel-coated coils for endovascular treatment of experimentally induced aneurysms. Long-term histological and scanning electron microscopy results.
Topics: Animals; Carotid Artery Diseases; Coated Materials, Biocompatible; Disease Models, Animal; Embolization, Therapeutic; Endothelium, Vascular; Hydrogel, Polyethylene Glycol Dimethacrylate; Intracranial Aneurysm; Microscopy, Electron, Scanning; Platinum; Rabbits; Radiography; Tunica Intima; Wound Healing | 2010 |
Fever-range whole body thermotherapy combined with oxaliplatin: a curative regimen in a pre-clinical breast cancer model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Disease Models, Animal; DNA Adducts; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fever; Hyperthermia, Induced; Organoplatinum Compounds; Oxaliplatin; Platinum; Rats; Rats, Inbred F344; Treatment Outcome | 2010 |
Simultaneous analysis of the local and systemic immune responses in mice to study the occupational asthma mechanisms induced by chromium and platinum.
Topics: Administration, Intranasal; Animals; Asthma; Cells, Cultured; Chromium; Disease Models, Animal; Female; Interleukin-13; Interleukin-4; Intubation, Intratracheal; Lymph Nodes; Mice; Mice, Inbred BALB C; Occupational Diseases; Platinum; Th1 Cells; Th2 Cells | 2010 |
High-resolution TOF MR angiography at 4.7 Tesla for volumetric and morphologic evaluation of coiled aneurysm neck remnants in a rat model.
Topics: Animals; Aortic Aneurysm, Abdominal; Computer Simulation; Disease Models, Animal; Embolization, Therapeutic; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Platinum; Rats | 2011 |
Strong neuroprotection with a novel platinum nanoparticle against ischemic stroke- and tissue plasminogen activator-related brain damages in mice.
Topics: Animals; Brain Infarction; Collagen Type IV; Disease Models, Animal; Drug Administration Schedule; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Matrix Metalloproteinase 9; Metal Nanoparticles; Mice; Mice, Inbred C57BL; Movement Disorders; Phenanthridines; Platinum; Reactive Oxygen Species; Regional Blood Flow; Reperfusion; Spectroscopy, Near-Infrared; Superoxides; Time Factors; Tissue Plasminogen Activator | 2012 |
Endoglin (CD105) contributes to platinum resistance and is a target for tumor-specific therapy in epithelial ovarian cancer.
Topics: Animals; Antigens, CD; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cell Survival; Disease Models, Animal; DNA Damage; DNA Repair; Drug Resistance, Neoplasm; Endoglin; Female; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Platinum; Receptors, Cell Surface; RNA Interference | 2013 |
SERPINB3 in the chicken model of ovarian cancer: a prognostic factor for platinum resistance and survival in patients with epithelial ovarian cancer.
Topics: 3' Untranslated Regions; Adult; Aged; Aged, 80 and over; Animals; Antigens, Neoplasm; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Transformation, Neoplastic; Chickens; Disease Models, Animal; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Ovary; Platinum; Prognosis; Serine Proteinase Inhibitors; Serpins | 2012 |
Development of a platinum complex as an anti-amyloid agent for the therapy of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Brain; Cell Survival; Coordination Complexes; Disease Models, Animal; Mice; Mice, Transgenic; Peptide Fragments; Platinum; Quinolines; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2013 |
Healing response in elastase-induced rabbit aneurysms after embolization with a new platinum coil system.
Topics: Animals; Carotid Artery, Common; Disease Models, Animal; Embolization, Therapeutic; Equipment Design; Equipment Safety; Follow-Up Studies; Intracranial Aneurysm; Pancreatic Elastase; Platinum; Rabbits; Radiography; Wound Healing | 2002 |
Antitumor and cellular pharmacological properties of a novel platinum(IV) complex: trans-[PtCl(2)(OH)(2)(dimethylamine) (isopropylamine)].
Topics: Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Cell Division; Disease Models, Animal; DNA; DNA Adducts; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Organoplatinum Compounds; Plasmids; Platinum; Serum Albumin; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
Basic fibroblast growth factor released from a platinum coil with a polyvinyl alcohol core enhances cellular proliferation and vascular wall thickness: an in vitro and in vivo study.
Topics: Animals; Cell Division; Disease Models, Animal; Drug Delivery Systems; Drug Implants; Embolization, Therapeutic; Endothelium, Vascular; Equipment Design; Fibroblast Growth Factor 2; In Vitro Techniques; Intracranial Aneurysm; Mice; Platinum; Polyvinyl Alcohol; Rats; Rats, Sprague-Dawley; Time Factors | 2003 |
Evaluation of isolated lung perfusion as neoadjuvant therapy of lung metastases using a novel in vivo pig model: II. High-dose cisplatin is well tolerated by the native lung tissue.
Topics: Animals; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Disease Models, Animal; Dose-Response Relationship, Drug; Hemodynamics; Hyperthermia, Induced; Lung; Lung Compliance; Lung Neoplasms; Neoadjuvant Therapy; Platinum; Pulmonary Gas Exchange; Respiratory Distress Syndrome; Swine; Vascular Resistance | 2004 |
Endovascular treatment of intracranial aneurysms: comparative evaluation in a terminal bifurcation aneurysm model in dogs.
Topics: Animals; Cerebral Angiography; Disease Models, Animal; Dogs; Embolization, Therapeutic; Evaluation Studies as Topic; Hydrogel, Polyethylene Glycol Dimethacrylate; Intracranial Aneurysm; Male; Platinum | 2004 |
MRI compatible electrodes for the induction of amygdala kindling in rats.
Topics: Amygdala; Animals; Carbon; Disease Models, Animal; Electric Stimulation; Electrodes, Implanted; Electroencephalography; Epilepsy; Gold; Iridium; Kindling, Neurologic; Magnetic Resonance Imaging; Male; Neurophysiology; Platinum; Rats; Rats, Wistar | 2006 |
Endoluminal cryotherapy to prevent recanalization after endovascular occlusion with platinum coils.
Topics: Aneurysm; Animals; Arterial Occlusive Diseases; Catheterization; Combined Modality Therapy; Cryotherapy; Disease Models, Animal; Dogs; Embolization, Therapeutic; Maxillary Artery; Platinum; Radiography; Secondary Prevention; Vertebral Artery | 2006 |
Endovascular treatment of experimental aneurysms by use of fibroblast-coated platinum coils: an angiographic and histopathologic study.
Topics: Actins; Animals; Biomarkers; Cells, Cultured; Cerebral Angiography; Disease Models, Animal; Embolization, Therapeutic; Female; Fibroblasts; Intracranial Aneurysm; Male; Myoblasts, Smooth Muscle; Platinum; Prostheses and Implants; Rabbits; Treatment Outcome; Vimentin; Wound Healing | 2007 |
Comparison of platinum and first-generation Matrix coils in under-packed canine side-wall aneurysms: evaluation of progressive thrombosis.
Topics: Aneurysm; Animals; Carotid Artery, Common; Coated Materials, Biocompatible; Disease Models, Animal; Dogs; Embolization, Therapeutic; Equipment Design; Platinum; Radiography; Thrombosis | 2007 |
Molecular indices of apoptosis activation in elastase-induced aneurysms after embolization with platinum coils.
Topics: Animals; Apoptosis; Carotid Artery, Common; Caspase 3; Caspase 8; Caspase 9; Disease Models, Animal; Embolization, Therapeutic; Fibroblasts; In Situ Nick-End Labeling; Intracranial Aneurysm; Pancreatic Elastase; Platinum; Proto-Oncogene Proteins c-bcl-2; Rabbits; Tumor Necrosis Factor-alpha | 2007 |
Repair capacity for platinum-DNA adducts determines the severity of cisplatin-induced peripheral neuropathy.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Analysis of Variance; Animals; Cisplatin; Deoxyguanine Nucleotides; Disease Models, Animal; DNA Adducts; DNA Repair; Electric Stimulation; Ganglia, Spinal; Male; Mice; Mice, Knockout; Neural Conduction; Neuroglia; Neurons; Organoplatinum Compounds; Peripheral Nervous System Diseases; Platinum; Time Factors; Xeroderma Pigmentosum Group A Protein | 2007 |
Electrochemical analysis of cell plasma membrane cholesterol at the airway surface of mouse trachea.
Topics: Animals; Biosensing Techniques; Cell Membrane; Cholesterol; Cholesterol Oxidase; Cystic Fibrosis; Disease Models, Animal; Electrochemistry; Fatty Acids; Mice; Microelectrodes; Platinum; Respiratory Mucosa; Sulfhydryl Compounds; Trachea | 2008 |
Pathogenesis of the platinum (cp) mutation, a model for oculocutaneous albinism.
Topics: Albinism, Oculocutaneous; Animals; Disease Models, Animal; Epitopes; Eye; Immunoblotting; Intramolecular Oxidoreductases; Isomerases; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Molecular Weight; Monophenol Monooxygenase; Mutation; Phenotype; Platinum; Tissue Extracts | 1993 |
Protective effects of glutathione on cisplatin neurotoxicity in rats.
Topics: Animals; Cisplatin; Disease Models, Animal; Drug Interactions; Female; Ganglia, Spinal; Glutathione; Neurons, Afferent; Peripheral Nervous System Diseases; Platinum; Rats; Rats, Wistar | 1994 |
Trypanocidal activity and platinum plasma kinetics of cis-Pt pentamidine iodide in Trypanosoma brucei sheep model.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Iodides; Male; Organoplatinum Compounds; Pentamidine; Platinum; Sheep; Tissue Distribution; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1993 |
[Intraperitoneal administration of carboplatin loaded alpha-tricalcium phosphate (alpha-TCP) particles in rats bearing abdominal carcinomatosis].
Topics: Animals; Antineoplastic Agents; Ascites; Biodegradation, Environmental; Calcium Phosphates; Carboplatin; Disease Models, Animal; Drug Carriers; Infusions, Parenteral; Male; Peritoneal Neoplasms; Platinum; Rats | 1996 |
Endovascular treatment of arteriovenous malformations with selective intranidal occlusion by detachable platinum electrodes: technical feasibility in a swine model.
Topics: Animals; Arteriovenous Fistula; Arteriovenous Malformations; Carotid Arteries; Contrast Media; Disease Models, Animal; Electrodes; Embolization, Therapeutic; Equipment Design; Feasibility Studies; Female; Foreign-Body Migration; Jugular Veins; Male; Microcirculation; Platinum; Pliability; Radiology, Interventional; Regional Blood Flow; Surface Properties; Swine | 1996 |
Platinum spatula versus Mini-tip Culturette in culturing bacterial keratitis.
Topics: Animals; Bacteria; Bacteriological Techniques; Colony Count, Microbial; Cornea; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Humans; Platinum; Rabbits; Sensitivity and Specificity | 1998 |
Platinum coil-mediated implantation of growth factor-secreting endovascular tissue grafts: an in vivo study.
Topics: Animals; Blood; Carotid Artery, Common; Cell Division; Cells, Cultured; Cicatrix; Collagen; Disease Models, Animal; DNA, Recombinant; Embolization, Therapeutic; Endothelium, Vascular; Fibroblast Growth Factor 2; Fibroblasts; Fibrosis; Follow-Up Studies; Humans; Intracranial Aneurysm; Mice; Mitogens; Platinum; Rats; Rats, Nude; Recurrence; Transplantation, Heterologous | 1998 |
Expression of renal aquaporins 1, 2, and 3 in a rat model of cisplatin-induced polyuria.
Topics: Animals; Antineoplastic Agents; Aquaporin 1; Aquaporin 2; Aquaporin 3; Aquaporin 6; Aquaporins; Blood Urea Nitrogen; Blotting, Northern; Body Weight; Cisplatin; Disease Models, Animal; Gene Expression; Immunoblotting; Kidney Tubules, Collecting; Kidney Tubules, Proximal; Male; Platinum; Polyuria; Rats; Rats, Sprague-Dawley; RNA, Messenger; Urinalysis; Vasopressins | 2000 |
Bioabsorbable polymeric material coils for embolization of intracranial aneurysms: a preliminary experimental study.
Topics: Absorbable Implants; Animals; Cerebral Angiography; Disease Models, Animal; Embolization, Therapeutic; Female; Fibrosis; Intracranial Aneurysm; Intracranial Thrombosis; Male; Materials Testing; Platinum; Swine | 2001 |
Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carcinoma, Hepatocellular; Cisplatin; Disease Models, Animal; Drug Evaluation, Preclinical; Injections, Intraperitoneal; Kidney; Kidney Function Tests; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Nude; Myocardium; Neoplasm Transplantation; Neural Conduction; Organoplatinum Compounds; Platinum; Rats; Rats, Wistar; Sciatic Nerve; Survival Rate; Tissue Distribution; Tumor Cells, Cultured; Ursodeoxycholic Acid | 2001 |
Transforming growth factor beta-coated platinum coils for endovascular treatment of aneurysms: an animal study.
Topics: Animals; Biotransformation; Blood Vessel Prosthesis; Cell Division; Disease Models, Animal; Embolization, Therapeutic; Equipment Design; Intracranial Aneurysm; Muscle, Smooth, Vascular; Platinum; Rabbits; Transforming Growth Factor beta | 2001 |
Alterations in cell cycle regulation underlie cisplatin induced apoptosis of dorsal root ganglion neurons in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Cycle; Cisplatin; Cyclin D1; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Ganglia, Spinal; Immunohistochemistry; In Situ Hybridization; In Situ Nick-End Labeling; Nerve Degeneration; Neurons, Afferent; Neurotoxins; Pain Measurement; Peripheral Nervous System Diseases; Platinum; Rats; Rats, Sprague-Dawley; Renal Insufficiency; RNA, Messenger; Up-Regulation | 2001 |
In situ beta radiation to prevent recanalization after coil embolization of cerebral aneurysms.
Topics: Animals; Axillary Artery; Brachytherapy; Disease Models, Animal; Dogs; Embolization, Therapeutic; Intracranial Aneurysm; Maxillary Artery; Platinum; Rabbits; Radioisotopes; Secondary Prevention; Swine; Treatment Outcome; Vertebral Artery | 2002 |
Pharmacomodulations on new organometallic complexes of Ir, Pt, Rh, Pd, Os: in vitro and in vivo trypanocidal study against Trypanosoma brucei brucei.
Topics: Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Tolerance; Female; Iridium; Lead; Mice; Organometallic Compounds; Osmium; Platinum; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 1992 |
T-cell-dependent popliteal lymph node reactions to platinum compounds in mice.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Immunologic; Drug Hypersensitivity; Immunity, Cellular; Injections, Subcutaneous; Leukocyte Count; Lymph Nodes; Mice; Mice, Inbred Strains; Mice, Nude; Organ Size; Platinum; T-Lymphocytes; Time Factors | 1992 |
Effect of chemotherapeutic agents on bladder cancer: a new animal model.
Topics: Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cyclophosphamide; Dactinomycin; Diamines; Disease Models, Animal; Doxorubicin; Fluorouracil; Hydroxyurea; Lomustine; Mice; Mice, Inbred C3H; Platinum; Urinary Bladder Neoplasms | 1973 |